Burton E. Sobel is Director at NEW RIVER PHARMACEUTICALS INC (NRPH). They have made 2 open-market trades across 1 company since 2006, most recently 2008-01-17.
CIK 0001196855
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NRPH | SELL · 10b5-1 | 2007-01-19 | 2007-01-22 | $56.10 | $281K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2007-01-03 | 2007-01-03 | $54.83 | $137K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-12-01 | 2006-12-05 | $49.01 | $368K | N/A | N/A | N/A |
| NUVO | SELL · 10b5-1 | 2006-11-10 | 2006-11-13 | $18.17 | $227K | N/A | N/A | N/A |
| NUVO | SELL | 2006-08-10 | 2006-08-14 | $16.00 | $200K | N/A | N/A | N/A |
| NUVO | SELL | 2006-05-25 | 2006-06-09 | $15.59 | $195K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-05-18 | 2006-05-19 | $29.21 | $584K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-03-20 | 2006-03-22 | $30.86 | $617K | N/A | N/A | N/A |
| ARIA | SELL · 10b5-1 | 2006-01-18 | 2006-01-20 | $6.50 | $27K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2006-01-09 | 2006-01-11 | $6.50 | $38K | -13.2% | +0.2% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.